4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-013040
CHIEF OPERATING OFFICER gave up 1,378 shares (to pay taxes)
- CHIEF OPERATING OFFICER acquired 4,691 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessari Eben CHIEF OPERATING OFFICER | 2023-09-01 | Option exercise | +2,727 | 122,794 | D | ||
| Tessari Eben CHIEF OPERATING OFFICER | 2023-09-01 | Shares withheld for taxes | −801 | $17.76 | $14,226 | 121,993 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2023-09-02 | Option exercise | +1,964 | 123,957 | D | ||
| Tessari Eben CHIEF OPERATING OFFICER | 2023-09-02 | Shares withheld for taxes | −577 | $17.76 | $10,248 | 123,380 | D |
| Derivatives | |||||||
| Tessari Eben CHIEF OPERATING OFFICER | 2023-09-01 | Option exercise · Restricted Share Unit | −2,727 | 8,178 | D | ||
| Tessari Eben CHIEF OPERATING OFFICER | 2023-09-01 | Grant or award · Restricted Share Unit | +7,091 | 7,091 | D | ||
| Tessari Eben CHIEF OPERATING OFFICER | 2023-09-01 | Grant or award · Share Option | +42,544 | 42,544 | D | ||
| Tessari Eben CHIEF OPERATING OFFICER | 2023-09-02 | Option exercise · Restricted Share Unit | −1,964 | 3,928 | D | ||
Loading xslF345X05/form4-09062023_110948.xml…